$QSI
Quantum-Si Inc Stock $qsi

$qsi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000114036124010438 Filed on February 29, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$400.0K	$1.082M	$0.00
YoY Change
Cost Of Revenue	$222.0K	$594.0K	$0.00
YoY Change
Gross Profit	$178.0K	$488.0K	$0.00
YoY Change
Gross Profit Margin	44.5%	45.1%
Selling, General & Admin	$11.60M	$44.63M	$42.30M
YoY Change	3.51%	5.53%	-15.97%
% of Gross Profit	6514.61%	9146.31%
Research & Development	$16.09M	$67.03M	$72.06M
YoY Change	-11.37%	-6.99%	54.72%
% of Gross Profit	9040.45%	13734.63%
Depreciation & Amortization	$1.093M	$4.156M	$2.584M
YoY Change	37.48%	60.84%	148.22%
% of Gross Profit	614.04%	851.64%
Operating Expenses	$27.69M	$111.7M	$123.8M
YoY Change	-5.69%	-9.84%	27.79%
Operating Profit	-$27.51M	-$111.2M	-$123.8M
YoY Change		-10.23%	27.79%
Interest Expense	$6.036M	$15.12M	$0.00
YoY Change	199.85%		-100.0%
% of Operating Profit
Other Income/Expense, Net	-$201.0K	$366.0K	-$20.15M
YoY Change	-105.45%	-101.82%	302.58%
Pretax Income	-$22.05M	-$95.96M	-$132.4M
YoY Change	-33.47%	-27.55%	39.43%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$22.05M	-$95.96M	-$132.4M
YoY Change	-33.47%	-27.55%	39.43%
Net Earnings / Revenue	-5512.0%	-8868.76%
Basic Earnings Per Share		-$0.68	-$0.95
Diluted Earnings Per Share	-$0.16	-$0.68	-$0.95
COMMON SHARES
Basic Shares Outstanding		141.3M	139.3M
Diluted Shares Outstanding		141.3M	139.3M

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$257.7M	$257.7M	$351.3M
YoY Change	-26.64%	-26.64%	-25.46%
Cash & Equivalents	$133.9M	$133.9M	$84.32M
Short-Term Investments	$123.9M	$123.9M	$267.0M
Other Short-Term Assets	$4.261M	$4.261M	$6.873M
YoY Change	-38.0%	-38.0%	17.13%
Inventory	$3.945M	$3.945M
Prepaid Expenses
Receivables	$368.0K	$368.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$266.3M	$266.3M	$358.2M
YoY Change	-25.65%	-25.65%	-24.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.28M	$30.71M	$32.61M
YoY Change	-3.41%	-5.81%	105.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$695.0K	$695.0K	$697.0K
YoY Change	-0.29%	-0.29%	1.01%
Total Long-Term Assets	$31.94M	$31.94M	$33.30M
YoY Change	-4.09%	-4.09%	27.82%
TOTAL ASSETS
Total Short-Term Assets	$266.3M	$266.3M	$358.2M
Total Long-Term Assets	$31.94M	$31.94M	$33.30M
Total Assets	$298.3M	$298.3M	$391.5M
YoY Change	-23.82%	-23.82%	-22.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.766M	$1.766M	$3.903M
YoY Change	-54.75%	-54.75%	15.03%
Accrued Expenses	$9.843M	$9.843M	$11.80M
YoY Change	-16.61%	-16.61%	45.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.61M	$11.61M	$15.71M
YoY Change	-26.09%	-26.09%	36.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$11.00K	$15.02M	$17.07M
YoY Change		-12.01%	16.43%
Total Long-Term Liabilities	$11.00K	$15.02M	$17.07M
YoY Change		-12.01%	16.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.61M	$11.61M	$15.71M
Total Long-Term Liabilities	$11.00K	$15.02M	$17.07M
Total Liabilities	$26.63M	$26.63M	$32.78M
YoY Change	-18.76%	-18.76%	25.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$495.6M
YoY Change	24.01%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$271.6M	$271.6M	$358.7M
YoY Change
Total Liabilities & Shareholders Equity	$298.3M	$298.3M	$391.5M
YoY Change	-23.82%	-23.82%	-22.2%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$22.05M	-$95.96M	-$132.4M
YoY Change	-33.47%	-27.55%	39.43%
Depreciation, Depletion And Amortization	$1.093M	$4.156M	$2.584M
YoY Change	37.48%	60.84%	148.22%
Cash From Operating Activities	-$20.97M	-$94.04M	-$90.56M
YoY Change	7.08%	3.84%	35.54%
INVESTING ACTIVITIES
Capital Expenditures	-$367.0K	$4.510M	$10.74M
YoY Change	-110.49%	-58.01%	86.38%
Acquisitions
YoY Change
Other Investing Activities	$60.70M	$148.7M	$147.9M
YoY Change	109.31%	0.52%	-133.23%
Cash From Investing Activities	$61.07M	$143.4M	$137.2M
YoY Change	139.47%	4.55%	-130.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-61.00K	149.0K	1.909M
YoY Change	-144.2%	-92.19%	-99.63%
NET CHANGE
Cash From Operating Activities	-20.97M	-94.04M	-90.56M
Cash From Investing Activities	61.07M	143.4M	137.2M
Cash From Financing Activities	-61.00K	149.0K	1.909M
Net Change In Cash	40.04M	49.54M	48.53M
YoY Change	561.13%	2.07%	-4414.13%
FREE CASH FLOW
Cash From Operating Activities	-$20.97M	-$94.04M	-$90.56M
Capital Expenditures	-$367.0K	$4.510M	$10.74M
Free Cash Flow	-$20.60M	-$98.55M	-$101.3M
YoY Change	-10.75%	-2.72%	39.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-111171000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-123841000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-96908000
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	9536000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.19
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141300000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141300000
CY2021	qsi	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	0
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139255000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79579000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79579000
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	90789268
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	195814000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-159725000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4156000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2584000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1041000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-136000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-91000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-70000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6243000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4379000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-400000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	176000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	36000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	8516000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1220000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	721000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	709000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1835000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4009000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4498000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2143000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	9368000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	8078000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-94036000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90560000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66813000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4510000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10741000
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4632000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	143428000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	137185000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-450937000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	357000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2757000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5618000
CY2023	qsi	Net Proceeds From Equity Infusion From Business Combination NetProceedsFromEquityInfusionFromBusinessCombination	0
CY2022	qsi	Net Proceeds From Equity Infusion From Business Combination NetProceedsFromEquityInfusionFromBusinessCombination	0
CY2022	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0
CY2021	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	1749000
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	149000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1909000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	516625000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	49541000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1125000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84319000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35785000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36910000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	133860000
CY2022	qsi	Cash Received From Exchange Of Research And Development Tax Credits CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits	0
CY2021	qsi	Cash Received From Exchange Of Research And Development Tax Credits CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits	173000
CY2023	qsi	Noncash Or Part Noncash Acquisition Forgiveness Of Related Party Promissory Notes NoncashOrPartNoncashAcquisitionForgivenessOfRelatedPartyPromissoryNotes	0
CY2022	qsi	Noncash Or Part Noncash Acquisition Forgiveness Of Related Party Promissory Notes NoncashOrPartNoncashAcquisitionForgivenessOfRelatedPartyPromissoryNotes	0
CY2021	qsi	Noncash Or Part Noncash Acquisition Forgiveness Of Related Party Promissory Notes NoncashOrPartNoncashAcquisitionForgivenessOfRelatedPartyPromissoryNotes	150000
CY2023	qsi	Noncash Or Part Noncash Acquisition Equity Related Transaction Costs From Business Combination NoncashOrPartNoncashAcquisitionEquityRelatedTransactionCostsFromBusinessCombination	0
CY2022	qsi	Noncash Or Part Noncash Acquisition Equity Related Transaction Costs From Business Combination NoncashOrPartNoncashAcquisitionEquityRelatedTransactionCostsFromBusinessCombination	151000
CY2021	qsi	Noncash Or Part Noncash Acquisition Equity Related Transaction Costs From Business Combination NoncashOrPartNoncashAcquisitionEquityRelatedTransactionCostsFromBusinessCombination	4232000
CY2023	qsi	Noncash Or Part Noncash Acquisition Equity Related Warrants From Business Combination NoncashOrPartNoncashAcquisitionEquityRelatedWarrantsFromBusinessCombination	0
CY2022	qsi	Noncash Or Part Noncash Acquisition Equity Related Warrants From Business Combination NoncashOrPartNoncashAcquisitionEquityRelatedWarrantsFromBusinessCombination	0
CY2021	qsi	Noncash Or Part Noncash Acquisition Equity Related Warrants From Business Combination NoncashOrPartNoncashAcquisitionEquityRelatedWarrantsFromBusinessCombination	11618000
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	195810000
CY2023	qsi	Noncash Or Part Noncash Acquisition Noncash Contingent Consideration And Holdbacks NoncashOrPartNoncashAcquisitionNoncashContingentConsiderationAndHoldbacks	0
CY2022	qsi	Noncash Or Part Noncash Acquisition Noncash Contingent Consideration And Holdbacks NoncashOrPartNoncashAcquisitionNoncashContingentConsiderationAndHoldbacks	0
CY2021	qsi	Noncash Or Part Noncash Acquisition Noncash Contingent Consideration And Holdbacks NoncashOrPartNoncashAcquisitionNoncashContingentConsiderationAndHoldbacks	1552000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84319000
CY2023Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	123876000
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	266990000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4261000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6873000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	266310000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	358182000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16275000
CY2023Q4	us-gaap	Assets Assets	298250000
CY2022Q4	us-gaap	Assets Assets	391485000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1766000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3903000
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1815000
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1270000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11609000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15706000
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1274000
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	996000
CY2023Q4	us-gaap	Liabilities Liabilities	26631000
CY2022Q4	us-gaap	Liabilities Liabilities	32779000
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	767239000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	758366000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	271619000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67025000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72062000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42296000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50333000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9483000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Operating Expenses OperatingExpenses	111659000
CY2022	us-gaap	Operating Expenses OperatingExpenses	123841000
CY2021	us-gaap	Operating Expenses OperatingExpenses	96908000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-95960000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-95960000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-132442000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132442000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-94989000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-94989000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139255000
CY2021	qsi	Temporary Equity Stock Issued During Period Issuance Costs TemporaryEquityStockIssuedDuringPeriodIssuanceCosts	4000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0
CY2021	qsi	Temporary Equity Stock Converted Shares Issued TemporaryEquityStockConvertedSharesIssued	90789268
CY2021	qsi	Temporary Equity Stock Converted Shares Issued Value TemporaryEquityStockConvertedSharesIssuedValue	195810000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	195810000
CY2021	qsi	Stock Issued During Period Value Business Combination StockIssuedDuringPeriodValueBusinessCombination	501170000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4232000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24918000
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	477034000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	151000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11206000
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	358706000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-95960000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132442000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-94989000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9483000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	278000
CY2023	qsi	Business Combination Change In Fair Value Of Stock Consideration BusinessCombinationChangeInFairValueOfStockConsideration	0
CY2022	qsi	Business Combination Change In Fair Value Of Stock Consideration BusinessCombinationChangeInFairValueOfStockConsideration	-320000
CY2021	qsi	Business Combination Change In Fair Value Of Stock Consideration BusinessCombinationChangeInFairValueOfStockConsideration	0
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	11206000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	24918000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2159000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1005000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4893000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	690000
CY2023	qsi	Increase Decrease In Other Assets Related Parties IncreaseDecreaseInOtherAssetsRelatedParties	0
CY2022	qsi	Increase Decrease In Other Assets Related Parties IncreaseDecreaseInOtherAssetsRelatedParties	0
CY2021	qsi	Increase Decrease In Other Assets Related Parties IncreaseDecreaseInOtherAssetsRelatedParties	-738000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5763000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	272510000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	148760000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	348000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2023	qsi	Payment For Deferred Consideration PaymentForDeferredConsideration	0
CY2022	qsi	Payment For Deferred Consideration PaymentForDeferredConsideration	500000
CY2021	qsi	Payment For Deferred Consideration PaymentForDeferredConsideration	0
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	28000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	48534000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84319000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35785000
CY2023	qsi	Cash Received From Exchange Of Research And Development Tax Credits CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits	1523000
CY2023	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Reclassifications</span></div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Certain prior year amounts have been reclassified for consistency with the current year’s presentation.</div>
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001816431
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2020Q3	qsi	Number Of Warrants Issued Per Unit Issued NumberOfWarrantsIssuedPerUnitIssued	0.33
CY2023	qsi	Standard Product Warranty Warranty Period StandardProductWarrantyWarrantyPeriod	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022	us-gaap	Advertising Expense AdvertisingExpense
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39486
CY2023	dei	Entity Registrant Name EntityRegistrantName	QUANTUM-SI INCORPORATED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1388175
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	29 Business Park Drive
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Branford
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06405
CY2023	dei	City Area Code CityAreaCode	866
CY2023	dei	Local Phone Number LocalPhoneNumber	688-7374
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	179300000
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133860000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	368000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0
CY2023Q4	us-gaap	Inventory Net InventoryNet	3945000
CY2022Q4	us-gaap	Inventory Net InventoryNet	0
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16849000
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	532000
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14438000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15757000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	695000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	697000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4943000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5548000
CY2023Q4	qsi	Accrued Contracted Services Current AccruedContractedServicesCurrent	1519000
CY2022Q4	qsi	Accrued Contracted Services Current AccruedContractedServicesCurrent	3616000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1566000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1369000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13737000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16077000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-495634000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399674000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	358706000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	298250000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391485000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1082000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	594000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	0
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	0
CY2023	us-gaap	Gross Profit GrossProfit	488000
CY2022	us-gaap	Gross Profit GrossProfit	0
CY2021	us-gaap	Gross Profit GrossProfit	0
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46575000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44634000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	0
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	0
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5000
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	5301000
CY2021	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2549000
CY2023	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	5587000
CY2022	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-20603000
CY2021	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-5023000
CY2023	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-278000
CY2022	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	6243000
CY2021	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	4379000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	366000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	458000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-95960000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-132442000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-94989000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5618000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-94989000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2757000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132442000
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	357000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8516000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-95960000
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	271619000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1402000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1249000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	415000
CY2023	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	5587000
CY2022	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-20603000
CY2021	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-5023000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	368000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3096000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0
CY2023	qsi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	83000
CY2022	qsi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	10033000
CY2021	qsi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	7388000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	7000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	763000
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0
CY2023	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	123809000
CY2022	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	834000
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	440542000
CY2023	qsi	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	208000
CY2022	qsi	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	0
CY2021	qsi	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	0
CY2021	qsi	Net Proceeds From Equity Infusion From Business Combination NetProceedsFromEquityInfusionFromBusinessCombination	512788000
CY2023	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	302000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1260000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1385000
CY2023	qsi	Deferred Offering Costs Payable DeferredOfferingCostsPayable	105000
CY2022	qsi	Deferred Offering Costs Payable DeferredOfferingCostsPayable	0
CY2021	qsi	Deferred Offering Costs Payable DeferredOfferingCostsPayable	0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Concentration of Business Risk</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and marketable securities. As of December 31, <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2023, the Company’s marketable securities consist of mutual funds, U.S. Treasury securities</span> and<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> commercial paper. As of December 31,</span> 2022, substantially all of the Company’s marketable securities were invested in fixed income mutual funds at one financial institution. For further information regarding realized losses related to marketable securities please refer to Note <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5</span>. Investments in Marketable Securities. The Company also maintains balances in certain operating accounts above federally insured limits and, as a result, the Company is exposed to credit risk in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation.</div> <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Company sources certain key materials and components utilized in the Company’s products from single or limited suppliers. Historically, the Company has not experienced significant issues sourcing these materials and components. However, if these suppliers were not able to supply the requested amount of materials or components, it could take a considerable length of time to obtain alternative sources, which could affect the Company’s development efforts and commercial operations</span>.</div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions about future events that affect the amounts recorded in its Consolidated Financial Statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions. Significant estimates and assumptions include:</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0); text-align: justify;">valuation allowances with respect to deferred tax assets;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0);">inventory valuation;</div> </td> </tr> </table> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">valuation of excess and obsolete inventory reserves;</div> </td> </tr> </table> </div> <div> <br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0);">valuation for acquisitions;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0);">valuation of goodwill;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0);">assumptions used for leases;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0); text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">valuation of warrant <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-indent: 24px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">liabilities;</span><br/> </div> </td> </tr> </table> <div> <br/> </div> <div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0);"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-indent: 24px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">assumptions associated with revenue recognition;</span> and</div> </td> </tr> </table> </div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"> <tr> <td style="width: 27pt;"><br/> </td> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0); text-align: justify;">assumptions underlying the fair value used in the calculation of the stock-based compensation.</div> </td> </tr> </table> <div><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company bases these estimates on historical and anticipated results and trends and on various other assumptions the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Consolidated Financial Statements.</div>
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P2Y
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9500000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	qsi	Standard Product Warranty Warranty Period StandardProductWarrantyWarrantyPeriod	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.80
CY2023	us-gaap	Advertising Expense AdvertisingExpense	400000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1400000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	9536000
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	5301000
CY2021	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2549000
CY2023	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	5587000
CY2022	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-20603000
CY2021	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-5023000
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	123854000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	22000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	123876000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	123876000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	0
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	123876000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1608000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	779000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	0
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1558000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0
CY2023Q4	us-gaap	Inventory Net InventoryNet	3945000
CY2022Q4	us-gaap	Inventory Net InventoryNet	0
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	3400000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26318000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23052000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10043000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6203000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16275000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16849000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4200000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2600000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	3478000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	3182000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1678000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1370000
CY2023	us-gaap	Lease Cost LeaseCost	5156000
CY2022	us-gaap	Lease Cost LeaseCost	4552000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4436000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4527000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4585000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4549000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2975000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	10053000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	31125000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6718000
CY2023Q4	qsi	Lease Incentives LeaseIncentives	9104000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	15303000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1566000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13737000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.079
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	4298000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2390000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	83000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10033000
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	519000
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0
CY2023Q4	qsi	Accrued Acquisition Related Fees Current AccruedAcquisitionRelatedFeesCurrent	0
CY2022Q4	qsi	Accrued Acquisition Related Fees Current AccruedAcquisitionRelatedFeesCurrent	343000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	979000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	839000
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	123000
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	194000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	88000
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1815000
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1270000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8516000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11206000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24918000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M6D
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-95960000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132442000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-94989000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-95960000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-95960000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-132442000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-132442000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-94989000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-94989000
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	141300000
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	139255000
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	79579000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141300000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141300000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139255000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139255000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79579000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79579000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.19
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27327388
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25414523
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16282263
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1300000
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1000000
CY2023	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-300000
CY2022	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	6200000
CY2021	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	4400000
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	0
CY2023	us-gaap	Restructuring Charges RestructuringCharges	4504000
CY2023	qsi	Restructuring Reserve Payments For Restructuring And Other Adjustments RestructuringReservePaymentsForRestructuringAndOtherAdjustments	3985000
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	519000
CY2023Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	0
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	519000
CY2023Q4	us-gaap	Restructuring And Related Cost Expected Cost Remaining1 RestructuringAndRelatedCostExpectedCostRemaining1	100000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-95977000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-132442000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-94989000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	17000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-95960000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-132442000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-94989000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0781
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.041
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.0145
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0068
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.019
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.028
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.0325
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.0317
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.005
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.016
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.009
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.006
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2152
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.274
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.33
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	89525000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	77008000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	9855000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	13358000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4528000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7309000
CY2023Q4	qsi	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	3385000
CY2022Q4	qsi	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	4344000
CY2023Q4	qsi	Deferred Tax Assets Unrealized Gain Loss On Debt Securities Trading DeferredTaxAssetsUnrealizedGainLossOnDebtSecuritiesTrading	2195000
CY2022Q4	qsi	Deferred Tax Assets Unrealized Gain Loss On Debt Securities Trading DeferredTaxAssetsUnrealizedGainLossOnDebtSecuritiesTrading	5724000
CY2023Q4	qsi	Deferred Tax Assets Capitalized Research And Development Expenses DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses	30878000
CY2022Q4	qsi	Deferred Tax Assets Capitalized Research And Development Expenses DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses	12005000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2938000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3925000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	143304000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	123673000
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	215000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	4258000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3558000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	381000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3773000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4639000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	139531000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	119034000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	139500000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	119000000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1310000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	69000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1379000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1400000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2023	qsi	Effective Income Tax Rate Reconciliation Tax Credit Research Exchanged For Cash Amount EffectiveIncomeTaxRateReconciliationTaxCreditResearchExchangedForCashAmount	200000
CY2022	qsi	Effective Income Tax Rate Reconciliation Tax Credit Research Exchanged For Cash Amount EffectiveIncomeTaxRateReconciliationTaxCreditResearchExchangedForCashAmount	200000
CY2021	qsi	Effective Income Tax Rate Reconciliation Tax Credit Research Exchanged For Cash Amount EffectiveIncomeTaxRateReconciliationTaxCreditResearchExchangedForCashAmount	900000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
qsi-20231231_def.xml	Edgar Link	unprocessable
0001140361-24-010438-index-headers.html	Edgar Link	pending
0001140361-24-010438-index.html	Edgar Link	pending
0001140361-24-010438.txt	Edgar Link	pending
0001140361-24-010438-xbrl.zip	Edgar Link	pending
ef20015319_10k.htm	Edgar Link	pending
ef20015319_ex10-13-3.htm	Edgar Link	pending
ef20015319_ex10-16.htm	Edgar Link	pending
ef20015319_ex23-1.htm	Edgar Link	pending
ef20015319_ex31-1.htm	Edgar Link	pending
ef20015319_ex31-2.htm	Edgar Link	pending
ef20015319_ex32.htm	Edgar Link	pending
ef20015319_ex4-1.htm	Edgar Link	pending
ef20015319_ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
image02.jpg	Edgar Link	pending
image03.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qsi-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
qsi-20231231_cal.xml	Edgar Link	unprocessable
qsi-20231231_lab.xml	Edgar Link	unprocessable
qsi-20231231_pre.xml	Edgar Link	unprocessable
ef20015319_10k_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QSI
Quantum-Si Inc Stock $qsi

2023 Q4 Form 10-K Financial Statement

#000114036124010438 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QSI Quantum-Si Inc Stock $qsi

2023 Q4 Form 10-K Financial Statement

#000114036124010438 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QSI
Quantum-Si Inc Stock $qsi